Activation and regulation mechanisms of NOD-like receptors based on structural biology.

Activation and regulation mechanisms of NOD-like receptors based on structural biology.
复制标题

基于结构生物学的NOD样受体的激活和调节机制。

DOI:
10.3389/fimmu.2022.953530
复制
发表时间:
2022
影响因子:
7.3
通讯作者:
--
中科院分区:
医学2区
文献类型:
--
作者:

文献摘要

被引文献

相似文献

先天免疫是抵御微生物感染的主要防御系统。先天免疫模式识别受体(PRRs)在检测入侵病原体中起着关键作用。当细菌和病毒等病原体侵入我们的身体时,它们的成分被PRRs识别为病原体相关分子模式(pathogen-associated molecular patterns, PAMPs),激活先天免疫系统。细胞成分,如DNA和RNA,作为损伤相关分子模式(DAMPs),在某些条件下也通过PRRs激活先天免疫。PRRs的激活引发炎症反应、干扰素介导的抗病毒反应和获得性免疫的激活。先天免疫受体的研究进展迅速。多种受体已被鉴定,其调控机制已被阐明。核苷酸结合和寡聚化结构域(NOD)样受体(NLRs)是细胞内PRRs的一个主要家族,不仅参与抵抗病原体入侵,还参与维持正常的体内平衡。已知一些NLRs形成称为炎性小体的多蛋白复合物,这一过程最终导致炎症细胞因子的产生,并通过蛋白水解级联诱导焦亡。nlr的异常激活已被发现与自身免疫性疾病有关。因此,NLRs被认为是药物发现的靶点,如抗病毒药物、免疫刺激剂、抗过敏药物和自身免疫性疾病药物。本文综述了近年来对nlr的激活和调控机制的研究,重点介绍了nlr的结构生物学。这些包括NOD2、神经元凋亡抑制蛋白(NAIP)/NLRC4、NLR家族pyrin结构域1 (NLRP1)、NLRP3、NLRP6和NLRP9。nlr与多种疾病有关,其基于结构生物学的详细激活机制有助于未来治疗药物的开发。
Innate immunity is a primary defense system against microbial infections. Innate immune pattern recognition receptors (PRRs) play pivotal roles in detection of invading pathogens. When pathogens, such as bacteria and viruses, invade our bodies, their components are recognized by PRRs as pathogen-associated molecular patterns (PAMPs), activating the innate immune system. Cellular components such as DNA and RNA, acting as damage-associated molecular patterns (DAMPs), also activate innate immunity through PRRs under certain conditions. Activation of PRRs triggers inflammatory responses, interferon-mediated antiviral responses, and the activation of acquired immunity. Research on innate immune receptors is progressing rapidly. A variety of these receptors has been identified, and their regulatory mechanisms have been elucidated. Nucleotide-binding and oligomerization domain (NOD)-like receptors (NLRs) constitute a major family of intracellular PRRs and are involved in not only combating pathogen invasion but also maintaining normal homeostasis. Some NLRs are known to form multi-protein complexes called inflammasomes, a process that ultimately leads to the production of inflammatory cytokines and induces pyroptosis through the proteolytic cascade. The aberrant activation of NLRs has been found to be associated with autoimmune diseases. Therefore, NLRs are considered targets for drug discovery, such as for antiviral drugs, immunostimulants, antiallergic drugs, and autoimmune disease drugs. This review summarizes our recent understanding of the activation and regulation mechanisms of NLRs, with a particular focus on their structural biology. These include NOD2, neuronal apoptosis inhibitory protein (NAIP)/NLRC4, NLR family pyrin domain containing 1 (NLRP1), NLRP3, NLRP6, and NLRP9. NLRs are involved in a variety of diseases, and their detailed activation mechanisms based on structural biology can aid in developing therapeutic agents in the future.